

![]() |
CDKN2A deletion in supratentorial ependymoma with RELA alteration indicates a dismal prognosis: a retrospective analysis of the HIT ependymoma trial cohort |
|
Authors | ![]() | |
Published in | Acta neuropathologica. 2020, vol. 140, no. 3, p. 405-407 | |
Keywords | Cohort Studies — Cyclin-Dependent Kinase Inhibitor p16 / deficiency — Cyclin-Dependent Kinase Inhibitor p16 / metabolism — Ependymoma / diagnosis — Ependymoma / drug therapy — Ependymoma / metabolism — Ependymoma / pathology — Humans — Prognosis — Supratentorial Neoplasms / metabolism — Supratentorial Neoplasms / pathology — Transcription Factor RelA / metabolism | |
Identifiers | PMID: 32514758 PMCID: PMC7423858 | |
Full text | ||
Structures | ||
Research group | Oncologie et hématologie pédiatriques (907) | |
Citation (ISO format) | JÜNGER, Stephanie T et al. CDKN2A deletion in supratentorial ependymoma with RELA alteration indicates a dismal prognosis: a retrospective analysis of the HIT ependymoma trial cohort. In: Acta neuropathologica, 2020, vol. 140, n° 3, p. 405-407. doi: 10.1007/s00401-020-02169-z https://archive-ouverte.unige.ch/unige:157308 |